Suppr超能文献

评估一种心理社会筛查工具在澳大利亚临床遗传学服务中患者和临床医生的可接受性、可行性和有用性。

Assessing the acceptability, feasibility, and usefulness of a psychosocial screening tool to patients and clinicians in a clinical genetics service in Australia.

机构信息

Parkville Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

Parkville Familial Cancer Centre and Genomic Medicine, Royal Melbourne Hospital, Melbourne, Victoria, Australia.

出版信息

J Genet Couns. 2022 Jun;31(3):653-662. doi: 10.1002/jgc4.1532. Epub 2021 Nov 17.

Abstract

Increasing demand for clinical genetic services may impact the resources and quality of genetic counseling, potentially impacting patient outcomes. Using a psychosocial screening tool may aid the provision of genetic counseling by reliably identifying patients' psychosocial needs. The Genetic Psychosocial Risk Instrument (GPRI) is a validated genetic-specific screening tool designed to identify psychological risk factors that predict distress in patients having genetic testing. This questionnaire-based study investigated the perceived acceptability, feasibility, and usefulness of the GPRI in patients and clinicians in routine clinical genetic practice. From December 2018 to January 2019, 154 patients attending an Australian clinical genetic service were invited to complete a paper-based survey that included the GPRI. The GPRI was scored and provided to the clinician for use in the appointment. In February 2019, clinicians completed an anonymous online survey regarding acceptability, feasibility, and usefulness of the GPRI. Descriptive statistics, chi-squared, t tests, and regression analyses were used to analyze the patient data, and descriptive statistics were employed for clinician surveys. A total of 145 patients participated (94% response rate). The average GPRI score was 46.3 (95% CI 43.6-49.0) with 41% of patients meeting the 50-point threshold indicating high risk for psychological distress. The GPRI was highly acceptable to patients, regardless of their level of psychosocial risk. Fourteen clinicians participated (54% response rate): 85% found the GPRI not too time consuming, and 86% believed it improved patient care by identifying patient needs. All were willing to use the GPRI routinely. The use of the GPRI is highly acceptable to patients and clinicians in this setting, assisting in identifying patients at risk for distress, prompting clinicians to address concerns, provide psychosocial support, and consider ongoing referral. As 41% of patients' scores indicated a high risk of distress, the GPRI is an important tool for potentially enhancing overall patient outcomes.

摘要

临床遗传服务需求的增加可能会影响遗传咨询的资源和质量,从而影响患者的治疗效果。使用心理社会筛查工具可以通过可靠地识别患者的心理社会需求来辅助遗传咨询的提供。遗传心理社会风险量表(GPRI)是一种经过验证的专门用于识别遗传检测患者心理风险因素的遗传特异性筛查工具,这些风险因素可预测患者的痛苦程度。本基于问卷的研究调查了 GPRI 在常规临床遗传实践中患者和临床医生的可接受性、可行性和有用性。2018 年 12 月至 2019 年 1 月,邀请了 154 名在澳大利亚临床遗传服务机构就诊的患者完成一份包括 GPRI 的纸质问卷调查。对 GPRI 进行评分,并将其提供给临床医生用于预约。2019 年 2 月,临床医生完成了一项关于 GPRI 可接受性、可行性和有用性的匿名在线调查。使用描述性统计、卡方检验、t 检验和回归分析来分析患者数据,并对临床医生调查采用描述性统计。共有 145 名患者参与(94%的回应率)。GPRI 的平均得分为 46.3(95%CI 43.6-49.0),其中 41%的患者达到 50 分的阈值,表明有较高的心理痛苦风险。无论患者的心理社会风险水平如何,GPRI 都受到患者的高度认可。有 14 名临床医生参与(54%的回应率):85%的临床医生认为 GPRI 不会太耗时,86%的临床医生认为通过识别患者的需求,GPRI 可以改善患者的护理。所有的临床医生都愿意常规使用 GPRI。在这种情况下,GPRI 受到患者和临床医生的高度认可,有助于识别有痛苦风险的患者,促使临床医生解决问题,提供心理社会支持,并考虑持续转介。由于 41%的患者的分数表明有较高的痛苦风险,因此 GPRI 是一个重要的工具,可以潜在地提高患者的整体治疗效果。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验